SEC Form D private-offering filing
Clover Biopharmaceuticals, Ltd.
A new SEC Form D private-offering notice from Chengdu, a $3,642,978 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage biotechnology company developing vaccines, including COVID 19 and RSV candidates, built on its Trimer Tag protein technology platform
Filed 2026-04-29Filed to raise $3,642,978First money in 2026-03-27Raised so far $3,642,978HQ (as filed) ChengduSector Biotech ✓Stage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified cloverbiopharma.com↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.